Back to search

Peptide record

TPDB42895

6F (I113-P122) Anticancer standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42895
6F (I113-P122)
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 20-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
RRRRRRRRGGILTVVELRVP
Physicochemical Analysis
C105H197N47O24
ANDCQHKMFSWY
R
2502.02
12.94
9
1
6
+8
8.70
-1.120
102.00
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
0
0.00
1
Residue Composition
number
0
A
9
R
0
N
0
D
0
C
1
E
0
Q
2
G
0
H
1
I
2
L
0
K
0
M
0
F
1
P
0
S
1
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 0 R: 9 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 2 H: 0 I: 1 L: 2 K: 0 M: 0 F: 0 P: 1 S: 0 T: 1 W: 0 Y: 0 V: 3
Chemical Descriptors
20
C105H197N47O24
2502.02
12.94
+8
8.70
-1.120
Free
L
Linear
Free
Anticancer
STAP-2 PH domain–derived peptide
Evidence Records 1 records
Evidence 1 Activity

Activity

Graph figure 1-D
Anticancer

Target

Liver Cancer
DU-145
Liver

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.